Takeda

Takeda Pharmaceutical Company Limited, commonly known as Takeda, is a prominent and well-established Japanese multinational pharmaceutical company. Founded in 1781, Takeda has a rich history and has evolved into one of the largest pharmaceutical companies in the world.

Takeda's core focus lies in research, development, and manufacturing of innovative pharmaceutical products. They are active in various therapeutic areas, including gastroenterology, oncology, neuroscience, rare diseases, and vaccines. The company's diverse product portfolio encompasses both prescription drugs and over-the-counter medications.

In recent years, Takeda has been involved in significant mergers and acquisitions to strengthen its global presence and expand its product offerings. One of the most notable acquisitions was the acquisition of Shire plc in 2019, which bolstered Takeda's position in rare diseases and other specialty areas.

Takeda places a strong emphasis on research and development, investing heavily in cutting-edge science and technologies. They collaborate with academic institutions, research organizations, and other pharmaceutical companies to drive innovation and develop breakthrough treatments.

Beyond their commitment to advancing healthcare, Takeda also actively engages in corporate social responsibility initiatives, focusing on sustainability, access to healthcare, and environmental conservation.

Founded: 1781

Founder: Chobei Takeda

Headquarters: Osaka, Japan

Website: https://www.takeda.com/jp/